Add to Favourites
To login click here
Telo Genomics Corp. has developed and implemented a machine learning and AI tool, CellSelect-Pro, to enhance the processing of samples in their TeloView myeloma diagnostic tests. The tool has shown high accuracy and precision in identifying and quantifying myeloma plasma cells, leading to potential cost savings and improved turnaround time. It has been successfully implemented in Telo’s testing workflows and is being used in their flagship product for smoldering multiple myeloma patients.
